Company Encyclopedia
View More
name
PROCAPS GROUP S.A.
PROCF.US
4.673 T
PROCF.USMarket value -Rank by Market Cap -/-

Financial Score

23/12/2025 Update
C
PharmaceuticalsIndustry
Industry Ranking91/186
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-224.21%E
    • Profit Margin9.52%B
    • Gross Margin56.16%B
  • Growth ScoreB
    • Revenue YoY5.10%C
    • Net Profit YoY11.67%C
    • Total Assets YoY6.77%B
    • Net Assets YoY98.02%A
  • Cash ScoreB
    • Cash Flow Margin1050.36%B
    • OCF YoY5.10%C
  • Operating ScoreA
    • Turnover0.93A
  • Debt ScoreE
    • Gearing Ratio100.16%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Procaps Group Announces December Shareholder Meetings for Key Corporate Changes

    Procaps Group has announced it will hold an extraordinary general meeting and an annual general meeting on December 5, 2025, to address key corporate changes. These include a proposed name change to Sofgen Pharma S.A. and the presentation of rectified financial statements due to past discrepancies. These actions aim to enhance transparency and compliance, potentially affecting market perception and stakeholder trust.

    Tip Ranks·
    US
    PROCF
    0.00%
    US
    PRCWF
    0.00%
    Tip Ranks·
    US
    PROCF
    0.00%
    US
    PRCWF
    0.00%

    Procaps Group SA Reports 5.1% Increase in Net Revenues to $423.7 Million for 2023; Constant Currency Basis Shows 5.7% Growth

    Procaps Group SA reported a 5.1% increase in net revenues to $423.7 million for 2023, with a constant currency growth of 5.7%. The revenue growth was driven by demand in strategic segments, particularly CASAND and Procaps Colombia, alongside new product introductions. Procaps Colombia's revenue rose by 4.5% to $148.7 million, with a slight increase in gross profit. The company continues to assess currency exchange impacts on its financial performance, providing both IFRS and constant currency results for investor evaluation.

    Reuters·
    US
    PROCF
    0.00%
    Reuters·
    US
    PROCF
    0.00%

    Procaps Group Appoints Luis Palacios as Chief Commercial Officer; Dr. Camilo Camacho Steps Down as Interim Co-CEO

    Procaps Group SA has announced a change in its executive management team. Dr. Camilo Camacho has stepped down as Interim Co-CEO, effective immediately, while Luis Palacios has been appointed as the new Chief Commercial Officer. These changes were made by the company's Board of Directors on July 25, 2025.

    Reuters·
    US
    PROCF
    0.00%
    Reuters·
    US
    PROCF
    0.00%

    Procaps Group SA Appoints Fernando Moreira Muniz and Carlos Romero-Camacho as New Board Directors Amid Management Restructuring

    Procaps Group SA has appointed Fernando Moreira Muniz and Carlos Romero-Camacho as new Board Directors, effective July 14, 2025. This follows the resignations of Jose Frugone Domke and Jorddy Antonio Pérez Galindo. Romero-Camacho will join the Compensation and Nominating Committees, while Moreira Muniz will join the Audit Committee. The company published this announcement via EDGAR, and it is responsible for the information provided.

    Reuters·
    US
    PRCWF
    0.00%
    US
    PROCF
    0.00%
    US
    PROCW
    0.00%
    Reuters·
    US
    PRCWF
    0.00%
    US
    PROCF
    0.00%
    US
    PROCW
    0.00%

    Procaps Group SA Appoints Carlos Garcia Iragorri and Manuel Vial as New Board Directors

    Procaps Group SA Appoints Carlos Garcia Iragorri and Manuel Vial as New Board Directors Procaps Group SA has announced the appointment of Carlos Garcia Iragorri and Manuel Vial as new members of its Board of Directors, filling the vacancies left by the resignations of Roberto Albisetti and Ernesto Carrizosa. Both appointments are effective as of May 8, 2025, and will continue until the annual general meeting of shareholders for the fiscal year ending December 31, 2025.

    Reuters·
    US
    PROCF
    0.00%
    Reuters·
    US
    PROCF
    0.00%
    © 2025 Longbridge｜Disclaimer